Grasp the new blue ocean of the big health industry to promote economic growth and overtake

Since March 2022, a new round of COVID-19 has spread, and China's economic development has been greatly impacted, greatly increasing the downside risks of the macro economy
.
Coordinating and balancing scientific epidemic prevention and economic and social orderly resumption of work and production and smooth operation has become a top priority at present
.
With the in-depth progress of "dynamic clearing" epidemic prevention and control, epidemic prevention materials and health consumption have become rigid needs of the people.
The market scale of China's big health industry has continued to expand, and the blue ocean market of more than 10 trillion yuan is gradually taking shape
.
01.
Market insights to clarify the market panorama of the big health industry The big health industry emphasizes the structural transformation of the traditional medical industry model, extending from a single treatment model to an integrated product and service model of "prevention-treatment-care"
.
From the perspective of the development of the global market, the big health industry has grown into one of the world's largest sunrise industries with strong development momentum
.
Biomedicine, digital medical care, high-end equipment, chronic disease management, elderly care industry and many other medical sub-sectors have ushered in a period of rapid development, and the big health industry has ushered in a new normal of global digitalization and full-link digitalization
.
● In terms of global market size and layout, the global pharmaceutical market will reach US$1,393.
5 billion in 2021, of which North America is the world's largest market with a market share of over 40%, with Johnson & Johnson, Bristol-Myers Squibb, AbbVie, Pfizer, Headquarters of leading multinational companies such as Merck & Co.
, Eli Lilly, etc.
, forming a modern biotechnology industry base in the San Francisco Bay Area; Europe is the second largest pharmaceutical market in the world, with a market share of more than 20%, gathering Roche, AstraZeneca, Novartis, Bayer and other leading multinationals The company headquarters has formed a cross-border biomedical industry center represented by Basel (Switzerland), Alsace (France) and South Baden (Germany); the combined market share of Asia and Africa is about 25%, and in the medical market , China has become the second largest market in the world after the United States
.
● From the perspective of the development stage of the global health industry segment, the fields of chemical generic drugs, branded traditional Chinese medicine, and low-end medical devices are relatively mature; innovative drugs, genetic testing, molecular diagnosis, medical robots, pharmaceutical e-commerce and other emerging industries Just in the ascendant; cell therapy, bioinformatics, etc.
are in the basic research stage and the initial stage of market introduction
.
● In terms of application scenarios, smart medical applications such as "service+", cloud, virtual testing and remote clinical trials, in-hospital robotic surgery and nursing, and artificial intelligence imaging diagnosis have become the future development trends of the global health industry
.
● In terms of biotechnology, gene therapy, CRISPR gene editing, tumor and Alzheimer's disease drug development, cell therapy, synthetic biology and other major disease-specific drug research and development, new therapies have become the research frontiers in the global biopharmaceutical field
.
The development of China's big health industry has formed a high-quality development pattern of two major tracks, medical products and services and health products and services
.
As the population aging rate continues to rise, the state's increase in medical insurance spending is the core driving factor for the development of China's big health industry.
With China's aging rate reaching 18.
9% in 2021, the combination of medical care and elderly care will become the largest health service field in the domestic market
.
● In terms of domestic market size and layout, in 2021, the market size of China's big health industry will reach 8 trillion yuan, an increase of 8.
1%.
Among them, the pharmaceutical industry accounts for more than half of the market share, followed by health care services, medical care, health care products and health care products.
There is still a lot of room for development in management, and the industrial structure needs to be improved; the industrial layout is concentrated in the eastern and southern coastal areas, showing a trend of agglomeration of multiple leaders
.
● From the perspective of top-level policy deployment, the "Healthy China 2030" strategy constitutes an important engine for the development of China's big health industry
.
The "14th Five-Year Plan for the Construction of High-quality and Efficient Medical and Health Service System Construction Implementation Plan" accelerates the construction of a strong public health system, promotes the expansion of high-quality medical resources and a balanced regional distribution, improves comprehensive and full-cycle health services and guarantee capabilities, and promotes the inheritance and innovation of traditional Chinese medicine.
Emphasize the integration of the medical and health service system and the level of response to public health events, and build major bases such as national medical centers and regional medical centers
.
The "14th Five-Year Plan for the Development of the Pharmaceutical Industry" proposes five major tasks: accelerating product innovation and industrialization technological breakthroughs, enhancing the stability and competitiveness of the industrial chain, enhancing supply guarantee capabilities, promoting the system upgrade of pharmaceutical manufacturing capabilities, and creating new advantages in international competition.
Combined with the technological development trend, five major projects are proposed in the form of columns, including the industrialization project of pharmaceutical innovative products, the technical research project of pharmaceutical industrialization, the supply guarantee project of vaccines and shortage drugs, the product quality upgrade project, and the green and low-carbon project of the pharmaceutical industry
.
Under the superposition of multiple strategies, along with the new development pattern of domestic circulation as the main body and mutual promotion of domestic and international dual circulation, based on the construction of a unified national market, China's big health industry has entered a stage of rapid development
.
02.
Anchor point positioning focuses on the core trends of the domestic big health industry.
Under the normalization of domestic epidemic prevention and control management and the influence of the epidemic, the national health consumption has risen, the aging population has accelerated, the prevalence of chronic diseases has risen, and the demand for personal health services has increased.
At the same time, cutting-edge medical technologies are constantly iterating, and new diagnostic equipment is being introduced one after another
.
Under the guidance of relevant policies, China's big health industry has accelerated breakthroughs in the fields of digital transformation, rehabilitation medical layout, medical payment innovation, whole-course management, medical carbon neutralization, precision medical treatment, and innovative medicine and equipment going overseas.
The hot spots of capital investment focus on Elderly care industry, health management, commercial medical insurance, medical beauty, online medical care, elderly care tourism, smart medical care, rehabilitation medical care, pharmaceutical e-commerce, gene sequence and other fields
.
03.
Layout thinking and judging the operation direction of the big health industry park Based on the social development requirements of precise epidemic prevention and control and enhancing the resilience of economic development, local governments or parks should strengthen the systematic layout for the development of the big health industry
.
● Distributing frontiers - Relying on the platform carrier within the jurisdiction, introducing third-party professional consulting agencies to create a high-tech, high-precision, cutting-edge technology that integrates policy interpretation, industry insight, medical scientific research achievement display, cutting-edge technology tracking and promotion, product application, academic special exchange and industry exchange An innovative comprehensive platform integrating talent training, actively deploying international frontier health technology hotspots, and promoting innovation capability and industrialization
.
● Strong characteristics - Relying on the advantages of local medical teaching and research resources, through objective and comprehensive analysis and demonstration, deploy and develop smart medical care, and develop comprehensive data collection, integration and sharing of public health, medical services, drug supply, and emergency early warning under the management of normalized epidemic prevention and control The information system that cooperates with the business integrates the supply guarantee of major disease prevention and treatment drugs, vaccines, protective materials, and diagnosis and treatment equipment, explores and opens up a variety of application scenarios that cover the needs of general health, and builds a characteristic brand of the regional general health industry
.
● Promoting opening up—diagnosing the whole chain of the big health industry, optimizing the planning of the big health industry in the park, carrying out institutional innovation and policy innovation in the big health industry, and improving the circulation of medicine, smart health manufacturing, Supporting industries such as health finance, help enterprises embedded in the industrial chain to accelerate coordinated development, and create a highland for the health industry with a highly open industry and international services
.